See Phan
Vice President, Clinical Research Oncology Gilead Sciences
Seminars
Tuesday 13th October 2026
Trodelvy-Immunotherapy & Beyond: Delving Into Clinical Data & Vision to Utilize Combination Therapies to Empower New Heights of ADC Patient Impact
2:00 pm
- Contextualizing ADC combinations as the future of effective clinical approaches as more ADCs advance to standard of care oncology settings
- Exploring ongoing work into Trodelvy-immunotherapy clinical combinations, focused on urothelial bladder cancer
- Highlighting rationale and vision for novel combinations to unlock the prospect of to deliver new heights of ADC powered patient impact
